A Missense Mutation in a Highly Conserved Region of CASQ2 Is Associated with Autosomal Recessive Catecholamine-Induced Polymorphic Ventricular Tachycardia in Bedouin Families from Israel

2001/12/01 by Hadas Lahat, Elon Pras, Tsviya Olender +11 · 27 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Cardiac electrophysiology and arrhythmias #Cardiovascular Effects of Exercise #Ion channel regulation and function

paper · pdf · doi:10.1086/324565

Cited by

• Role of Sodium and Calcium Dysregulation in Tachyarrhythmias in Sudden Cardiac Death
• Calcium Signaling and Cardiac Arrhythmias
• KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. [europepmc]
• Calcium and arrhythmogenesis. [europepmc]
• Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. [europepmc]
• Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia. [europepmc]
• Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. [europepmc]
• Ryanodine receptor channelopathies. [europepmc]
• Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. [europepmc]
• Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia. [europepmc]
• Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. [europepmc]
• Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. [europepmc]
• Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. [europepmc]
• Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy. [europepmc]
• The human protein disulfide isomerase gene family. [europepmc]
• Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia. [europepmc]
• Role of sodium and calcium dysregulation in tachyarrhythmias in sudden cardiac death. [europepmc]
• Cardiac innervation and sudden cardiac death. [europepmc]
• Ion Channels in the Heart. [europepmc]
• CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift. [europepmc]
• Cardiac Channelopathies and Sudden Death: Recent Clinical and Genetic Advances. [europepmc]
• Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial. [europepmc]
• Calcium Signaling and Cardiac Arrhythmias. [europepmc]
• Multi-ethnic genome-wide association study for atrial fibrillation. [europepmc]
• Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia. [europepmc]
• Calcium Handling Defects and Cardiac Arrhythmia Syndromes. [europepmc]
• RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVT. [europepmc]